Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: X
Results 1 - 10 of 18 shown below

  • X chromosome

    G Boily, Z Saikali and D Sinnett

    Methylation analysis of the glypican 3 gene in embryonal tumours

    advance online publication, 2004-03-23 00:00:00.000;

    doi:10.1038/sj.bjc.6601716

  • X-chromosomal inactivation

    X Bu, L Bernstein and R K Brynes

    Reduced risk of synovial sarcoma in females: X-chromosome inactivation?

    doi:10.1038/sj.bjc.6600362

  • X-chromosome inactivation

    S B Middleton, I M Frayling and R K S Phillips

    Desmoids in familial adenomatous polyposis are monoclonal proliferations

    doi:10.1054/bjoc.1999.1007

  • X-irradiation

    H Yasui, A Ogura, T Asanuma, A Matsuda, I Kashiwakura, M Kuwabara and O Inanami

    Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo

    advance online publication, 2008-10-14 00:00:00.000;

    doi:10.1038/sj.bjc.6604720

  • T Yajima, A Yagihashi, H Kameshima, D Kobayashi, K Hirata and N Watanabe

    Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells

    doi:10.1054/bjoc.2001.1954

  • X-rays

    J van Rijn, J van den Berg, T Teerlink, F A E Kruyt, D S M Schor, A C Renardel de Lavalette, T K van den Berg, C Jakobs and B J Slotman

    Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells

    doi:10.1038/sj.bjc.6600700

  • xanthine oxidase

    M Korbelik, J Sun and H Zeng

    Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours

    doi:10.1038/sj.bjc.6600792

  • xenogeneic cells

    E Tartour, M Mehtali, X Sastre-Garau, I Joyeux, C Mathiot, J M Pleau, P Squiban, C Rochlitz, M Courtney, P Jantscheff, R Herrmann, P Pouillart, W H Fridman and T Dorval

    Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

    doi:10.1054/bjoc.2000.1492

  • xenograft

    W Budach, F Paulsen, S Welz, J Classen, H Scheithauer, P Marini, C Belka and M Bamberg

    Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma

    doi:10.1038/sj.bjc.6600081

  • M Lindskog, P Kogner, F Ponthan, P Schweinhardt, B Sandstedt, T Heiden, G Helms and C Spenger

    Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS)

    doi:10.1038/sj.bjc.6600704

  • P Leuraud, L Taillandier, L Aguirre-Cruz, J Medioni, E Crinière, Y Marie, A M Dutrillaux, M Kujas, A Duprez, J-Y Delattre, M-F Poupon and M Sanson

    Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice

    doi:10.1038/sj.bjc.6601466

  • Y Honma, Y Yamamoto-Yamaguchi and Y Kanatani

    Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice

    doi:10.1038/sj.bjc.6690327

  • E Jacobs, S A Watson, D Michaeli, I O Ellis and J F R Robertson

    Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts

    doi:10.1038/sj.bjc.6690362

  • U B Hofmann, J R Westphal, E T Waas, A J W Zendman, I M H A Cornelissen, D J Ruiter and G N P van Muijen

    Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

    doi:10.1038/sj.bjc.6690763

  • H Naundorf, M Becker, A E Lykkesfeldt, B Elbe, C Neumann, B Büttner and I Fichtner

    Development and characterization of a tamoxifen-resistant breast carcinoma xenograft

    doi:10.1054/bjoc.2000.1156

  • K J Harrington, G Rowlinson-Busza, K N Syrigos, R M Abra, P S Uster, A M Peters and J S W Stewart

    Influence of tumour size on uptake of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model

    doi:10.1054/bjoc.2000.1320

  • xenograft tumour

    K J Harrington, G Rowlinson-Busza, K N Syrigos, P S Uster, R M Abra and J S W Stewart

    Biodistribution and pharmacokinetics of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies

    doi:10.1054/bjoc.1999.1232

  • xenografts

    M Becker, A Nitsche, C Neumann, J Aumann, I Junghahn and I Fichtner

    Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems

    doi:10.1038/sj.bjc.6600573

  • B Geoerger, J Grill, P Opolon, J Morizet, G Aubert, Y Lecluse, V W van Beusechem, W R Gerritsen, D H Kirn and G Vassal

    Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

    doi:10.1038/sj.bjc.6601102

  • I C Harkes, F Elstrodt, W N M Dinjens, M Molier, J G M Klijn, E M J J Berns and M Schutte

    Allelotype of 28 human breast cancer cell lines and xenografts

    doi:10.1038/sj.bjc.6601448

  • S M Harris, P Mistry, C Freathy, J L Brown and P A Charlton

    Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines

    advance online publication, 2005-02-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602403

  • E Oikonomou, K Kothonidis, G Zografos, G Nasioulas, L Andera and A Pintzas

    Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo

    advance online publication, 2007-06-05 00:00:00.000;

    doi:10.1038/sj.bjc.6603835

  • R Fanciullino, S Giacometti, C Mercier, C Aubert, C Blanquicett, P Piccerelle and J Ciccolini

    In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation

    advance online publication, 2007-09-11 00:00:00.000;

    doi:10.1038/sj.bjc.6603970

  • Q Chang, C Jorgensen, T Pawson and D W Hedley

    Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer

    advance online publication, 2008-09-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604676

  • W M van Weerden, C Bangma and R de Wit

    Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer

    advance online publication, 2008-12-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604822

  • E Marangoni, N Lecomte, L Durand, G de Pinieux, D Decaudin, C Chomienne, F Smadja-Joffe and M-F Poupon

    CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

    advance online publication, 2009-02-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604953

  • H-B Ris, T Krueger, A Giger, C K Lim, J C M Stewart, U Althaus and H J Altermatt

    Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts

    doi:10.1038/sj.bjc.6690170

  • M A Konerding, W Malkusch, B Klapthor, C van Ackern, E Fait, S A Hill, C Parkins, D J Chaplin and M Presta

    Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts

    doi:10.1038/sj.bjc.6690416

    • Result page: